These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32065799)

  • 41. Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
    Blum S; Milman U; Shapira C; Miller-Lotan R; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):e18-20. PubMed ID: 18296583
    [No Abstract]   [Full Text] [Related]  

  • 42. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
    Levy Y; Blum S; Levy AP
    Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice.
    Dahan I; Thawho N; Farber E; Nakhoul N; Asleh R; Levy AP; Li YC; Ben-Izhak O; Nakhoul F
    J Diabetes Res; 2018; 2018():7163652. PubMed ID: 30250850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
    Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
    Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.
    Suleiman M; Aronson D; Asleh R; Kapeliovich MR; Roguin A; Meisel SR; Shochat M; Sulieman A; Reisner SA; Markiewicz W; Hammerman H; Lotan R; Levy NS; Levy AP
    Diabetes; 2005 Sep; 54(9):2802-6. PubMed ID: 16123372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum vitamin C concentration is influenced by haptoglobin polymorphism and iron status in Chinese.
    Na N; Delanghe JR; Taes YE; Torck M; Baeyens WR; Ouyang J
    Clin Chim Acta; 2006 Mar; 365(1-2):319-24. PubMed ID: 16256097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.
    Lioupis C; Barbatis C; Drougou A; Koliaraki V; Mamalaki A; Klonaris C; Georgopoulos S; Andrikopoulos V; Bastounis E
    Atherosclerosis; 2011 May; 216(1):131-8. PubMed ID: 21316675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haptoglobin genotype and endothelial function in diabetes mellitus: a pilot study.
    Dayan L; Levy AP; Blum S; Miller-Lotan R; Melman U; Alshiek J; Jacob G
    Eur J Appl Physiol; 2009 Jul; 106(4):639-44. PubMed ID: 19347351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS).
    Mayer-Davis EJ; Costacou T; King I; Zaccaro DJ; Bell RA;
    Diabetes Care; 2002 Dec; 25(12):2172-7. PubMed ID: 12453956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between haptoglobin 2-2 genotype and coronary artery disease and its severity in a tunisian population.
    Moussa A; Rejeb J; Omezzine A; Rebhi L; Boumaiza I; Kacem S; Ben Rejeb N; Boughzala E; Ben Abdelaziz A; Bouslama A
    Biochem Genet; 2014 Jun; 52(5-6):269-82. PubMed ID: 24535155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans.
    Park KU; Song J; Kim JQ
    J Clin Pathol; 2004 Oct; 57(10):1094-5. PubMed ID: 15452167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables.
    Braeckman L; De Bacquer D; Delanghe J; Claeys L; De Backer G
    Atherosclerosis; 1999 Apr; 143(2):383-8. PubMed ID: 10217368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population.
    Amor AJ; Canivell S; Oriola J; Ricart MJ; de Hollanda AM; Bosch-Comas A; Esmatjes E
    Nefrologia; 2014; 34(2):212-5. PubMed ID: 24658196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study.
    Zhou J; Liu J; Sheng H; You N; Chen J; Mi X; Yang W; Zang S; Shi J;
    Adv Ther; 2019 Apr; 36(4):880-895. PubMed ID: 30820874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
    Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
    Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Orchard TJ; Backlund JC; Costacou T; Cleary P; Lopes-Virella M; Levy AP; Lachin JM;
    J Diabetes Complications; 2016; 30(8):1577-1584. PubMed ID: 27539884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitamin E and diabetic nephropathy in mice model and humans.
    Farid N; Inbal D; Nakhoul N; Evgeny F; Miller-Lotan R; Levy AP; Rabea A
    World J Nephrol; 2013 Nov; 2(4):111-24. PubMed ID: 24255894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
    Roguin A; Koch W; Kastrati A; Aronson D; Schomig A; Levy AP
    Diabetes Care; 2003 Sep; 26(9):2628-31. PubMed ID: 12941730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of haptoglobin on the metabolism of vitamin C.
    Langlois MR; Delanghe JR; De Buyzere ML; Bernard DR; Ouyang J
    Am J Clin Nutr; 1997 Sep; 66(3):606-10. PubMed ID: 9280180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.